Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2000
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046237A1 Brain-derived alkali-soluble immunoregulatory composition
08/10/2000WO2000046236A2 Novel rgs-containing molecules and uses thereof
08/10/2000WO2000046233A1 Pigment protein from coral tissue
08/10/2000WO2000045853A2 Treatment of tumors with genetically engineered herpes virus
08/10/2000WO2000045852A1 Method of treating cancer by restoration of pp32 function
08/10/2000WO2000045843A1 Novel sialoadhesins
08/10/2000WO2000045838A1 A METHOD FOR TARGETED DEGRADATION OF INTRACELLULAR PROTEINS IN VIVO OR $i(EX VIVO)
08/10/2000WO2000045831A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000WO2000045771A2 Suppression of transformation of cells by the transcription factor egr
08/10/2000WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor
08/10/2000WO2000036109B1 Maize rad2/fen-1 orthologues and uses thereof
08/10/2000WO2000034335A3 'death domain' containing receptors
08/10/2000WO2000033084A3 Arrays of organic compounds attached to surfaces
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000026389A3 Dna comprising rice anther-specific gene and transgenic plant transformed therewith
08/10/2000WO2000026368A3 Therapeutic antiangiogenic endostatin compositions
08/10/2000WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000025827A3 Dna molecules encoding muc-1 and use thereof in tumor vaccination
08/10/2000WO2000024870A3 Nucleic acids and proteins of the human span-x gene and uses thereof
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000024767A3 Human membrane associated protein 'zsig24' and encoding gene as marker for metabolic disease
08/10/2000WO2000023583A3 p53 BINDING AREAS
08/10/2000WO2000016746A8 Immunogenic liposome compositions
08/10/2000WO2000012754A8 Method for identifying substances for the treatment of c-jun-mediated disorders
08/10/2000WO2000012715A9 Modification of plant fibres
08/10/2000WO2000012707A9 14926 receptor, a novel g-protein coupled receptor
08/10/2000WO2000011020A9 Deoxyhypusine reagent and peptides
08/10/2000WO2000004190A9 Evolution of whole cells and organisms by recursive sequence recombination
08/10/2000WO2000003699A3 Drugs containing phosphoric acid derivatives as active ingredient and their use
08/10/2000WO2000002997B1 Transgenic mouse expressing green fluorescent protein in astrocytes
08/10/2000WO1999063086A8 Insulin-like growth factor binding protein-3 variants
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000WO1999006547A3 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
08/10/2000DE19905128A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid
08/10/2000DE19903876A1 Verfahren zur Induktion von prophylaktisch oder therapeutisch wirksamen Proteinen Method of inducing a prophylactic or therapeutically effective proteins
08/10/2000DE19903125A1 Verfahren zur Trocknung von Proteinkristallen Process for drying protein crystals
08/10/2000DE19903087A1 Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern Treatment of erectile dysfunction with C-type natriuretic polypeptide (CNP) as monotherapy or in combination with phosphodiesterase inhibitors
08/10/2000CA2371794A1 Human antibiotic proteins
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362231A1 Brain-derived alkali-soluble immunoregulatory composition
08/10/2000CA2362196A1 Prostate, testis and uterine polypeptide zpep14
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361838A1 Method of treating cancer by restoration of pp32 function
08/10/2000CA2361678A1 Method of modulating metabolite biosynthesis in recombinant cells
08/10/2000CA2361658A1 T helper cell epitopes
08/10/2000CA2361612A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000CA2361038A1 Pigment protein from coral tissue
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2360834A1 Candida albicans srb-7
08/10/2000CA2360800A1 Inhibition of the mhc class ii antigen presentation pathway and presentation to cd4+ cells
08/10/2000CA2360745A1 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation
08/10/2000CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2360640A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance
08/09/2000WO2000052043A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026252A1 Synthetic gene of bovine viral diarrhoea virus
08/09/2000EP1026251A2 Transgenic animals expressing human P25
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
08/09/2000EP1026240A2 Generation and selection of recombinant varied binding proteins
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026172A1 Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025256A2 Method for identifying binding ligands to receptors
08/09/2000EP1025253A1 Positive-negative selection for homologous recombination
08/09/2000EP1025246A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins
08/09/2000EP1025245A2 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
08/09/2000EP1025244A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/09/2000EP1025242A1 A method of inhibiting an immune response to a recombinant vector
08/09/2000EP1025234A1 Binary viral expression system in plants
08/09/2000EP1025233A2 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
08/09/2000EP1025232A1 A novel mitogenic cyclin and uses thereof
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025229A1 Chemokines with amino-terminal modifications
08/09/2000EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025226A1 Dna encoding a human proton-gated ion channel and uses thereof
08/09/2000EP1025225A1 P-40/annexin i and related proteins and their role in multidrug resistance
08/09/2000EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025222A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function
08/09/2000EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
08/09/2000EP1025218A1 Method to screen phage display libraries with different ligands
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025206A1 Cell lines useful for (in vitro) assay for identification of carcinogens
08/09/2000EP1025205A2 (in vitro) differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/09/2000EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals
08/09/2000EP1025128A1 Dna molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby
08/09/2000EP1025127A1 Msh-receptor subtype selective cyclic peptides
08/09/2000EP1025126A1 Purification of molecules
08/09/2000EP1025125A1 Aggregates of human insulin derivatives
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
1 ... 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 ... 2916